TROKENDI XR 50 MG CAPSULE

topiramate
$16.2575per EA

Strength

50 mg/1

NDC

17772010230

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA201635

On Market Since

8/16/2013

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

-0.1%

3M

+0.3%

6M

+0.3%

1Y

+6.3%

3Y

+5.9%

5Y

+19.1%

All

+58.1%